Uncategorized
VIDEO: Speaker presents 1 year results from phase 1/2 trial of bimatoprost implant
PRAGUE — At the European Glaucoma Society Congress, Keith Martin, MA, DM, MRCP, FRCOphth, discusses interim 1 year results of the phase 1/2 trial of Allergan's sustained-release bimatoprost implant for the treatment of glaucoma.